The effect of artificial antigen-presenting cells with preclustered anti-CD28/-CD3/-LFA-1 monoclonal antibodies on the induction of ex vivo expansion of functional human antitumor T cells.
Zappasodi R
Haematologica. 2008 Aug 25;93(10):1523-34. doi: 10.3324/haematol.12521
Highly efficient gene transfer into mobilized CD34+ hematopoietic cells using serotype-5 adenoviral vectors and BoosterExpress Reagent.
Lavazza C
Exp Hematol. 35(6):888-97.
Long-term lymphoma survivors following high-dose chemotherapy and autograft: evidence of permanent telomere shortening in myeloid cells, associated with marked reduction of bone marrow hematopoietic stem cell reservoir.
Rocci A
Exp Hematol. 35(4):673-81.
Forced expression of RDH10 gene retards growth of HepG2 cells.
Rossi E
Cancer Biol Ther. 2007 Feb 25;6(2):238-44.
Placental growth factor-1 potentiates hematopoietic progenitor cell mobilization induced by granulocyte colony-stimulating factor in mice and nonhuman primates.
Carlo-Stella C
Stem Cells. 2006 Sep 28;25(1):252-61.
Antitumor activity of human CD34+ cells expressing membrane-bound tumor necrosis factor-related apoptosis-inducing ligand.
Carlo-Stella C
Hum Gene Ther. 17(12):1225-40.
CD52 antigen expressed by malignant plasma cells can be targeted by alemtuzumab in vivo in NOD/SCID mice.
Carlo-Stella C
Exp Hematol. 34(6):721-7.
Topical prophylaxis of conjunctivitis induced by high-dose cytosine arabinoside.
Matteucci P
Haematologica. 91(2):255-7.
The anti-human leukocyte antigen-DR monoclonal antibody 1D09C3 activates the mitochondrial cell death pathway and exerts a potent antitumor activity in lymphoma-bearing nonobese diabetic/severe combined immunodeficient mice.
Carlo-Stella C
Cancer Res. 66(3):1799-808.
Skewed T-cell differentiation in patients with indolent non-Hodgkin lymphoma reversed by ex vivo T-cell culture with gammac cytokines.
Anichini A
Blood. 2005 Sep 8;107(2):602-9.